19:19:56 EDT Tue 26 May 2020
Enter Symbol
or Name

Login ID:
Aphria Inc
Symbol APHA
Shares Issued 250,710,023
Close 2019-05-09 C$ 9.11
Recent Sedar Documents

FP/CP say Canopy, rivals hear call for CBD rule change

2019-05-09 07:13 ET - In the News

See In the News (C-WEED) Canopy Growth Corp

The Financial Post reports in its Thursday, May 9, edition that Health food and hemp industry groups are calling on Ottawa to change the regulations for CBD to treat the cannabinoid as a natural health product rather than a drug. The Canadian Press dispatch to the Post reports that the Canadian Health Food Association and the Canadian Hemp Trade Alliance say CBD, a non-intoxicating compound which can be derived from cannabis and hemp, should be removed from the prescription drug list. The groups also asked in a joint paper for a regulatory pathway to allow for CBD derived from industrial hemp to be included in natural health products and supplemented foods, with the appropriate therapeutic and wellness claims. CBD is regulated similarly to cannabis and must be purchased through a legal retailer or, for medical patients, through a licensed producer or seller.

© 2020 Canjex Publishing Ltd. All rights reserved.